azomycin has been researched along with imipenem, anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Munro, R; Shanker, S; Toohey, M | 1 |
| Khalid, UK; Mathuria, KK; Munjal, SK; Myneedu, VP; Puri, MM; Sarin, R; Singla, N; Singla, R; Verma, A; Vohra, V | 1 |
| Hussar, DA | 1 |
3 other study(ies) available for azomycin and imipenem, anhydrous
| Article | Year |
|---|---|
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gardnerella vaginalis; Haemophilus; Imipenem; Microbial Sensitivity Tests; Nitroimidazoles; Quinolines; Quinolones; Thienamycins | 1982 |
Early efficacy and safety of Bedaquiline and Delamanid given together in a "Salvage Regimen" for treatment of drug-resistant tuberculosis.
Topics: Adult; Cardiotoxicity; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Electrocardiography; Female; Humans; Imipenem; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Salvage Therapy; Sputum; Survival Rate; Tuberculosis, Multidrug-Resistant; Young Adult | 2019 |
New drugs 2020, part 3.
Topics: Aminophenols; Antibodies, Monoclonal, Humanized; Azabicyclo Compounds; Benzodioxoles; beta-Cyclodextrins; Cilastatin; Drug Approval; Drug Combinations; Ethinyl Estradiol; Genetic Vectors; Humans; Imipenem; Indoles; Nitroimidazoles; Pregnanolone; Pregnenediones; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Retinoids; United States; United States Food and Drug Administration | 2020 |